Zevra Therapeutics, Inc. Convertible Notes Payable, Noncurrent
Zevra Therapeutics, Inc. (ZVRA) had Convertible Notes Payable, Noncurrent of $0 as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Excluding Current Maturities › Notes and Loans, Noncurrent › Notes Payable, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2022-03-31
- 2021-12-31: Convertible Notes Payable, Noncurrent $0.00.
- 2021-09-30: Convertible Notes Payable, Noncurrent $0.00.
- 2021-06-30: Convertible Notes Payable, Noncurrent $0.00.
- 2020-12-31: Convertible Notes Payable, Noncurrent $67.66M.
| Period end | Convertible Notes Payable, Noncurrent | Convertible Notes Payable, Noncurrent as first filed |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-31 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-13 | |
| 2020-12-31 | $67.66M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $77.34M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $70.55M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $75.55M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $75.37M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $78.11M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $87.17M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $86.84M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $89.79M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $89.40M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $92.34M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $91.95M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $91.56M 10-Q · filed 2017-05-22 | |
| 2016-12-31 | $91.17M 10-K · filed 2018-03-30 | |
| 2016-09-30 | $90.78M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $90.39M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $90.09M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $7.41M 10-K · filed 2017-03-10 | $7.87M 10-K · filed 2016-03-16 |
| 2015-09-30 | $7.71M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $7.55M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $7.39M 10-Q · filed 2015-05-29 | |
| 2014-12-31 | $7.24M 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |